Cibacen, Ciba-Geigy: New Zealand
tablet 5, 10, 20 mg
angiotensin-converting enzyme (ACE) inhibitor
New indication: Renal insufficiency.
Neupogen, Roche: New Zealand
solution for injection 0.3 mg/ml
non-glycosylated recombinant methionyl human granulocyte-colony stimulating factor (G-CSF)
Extended indications: Prophylaxis of infections associated with severe neutropenia in children at risk (for example, patients undergoing cytostatic therapy for non-myeloid cancer, or those with severe idiopathic or congenital neutropenia). Note: Already approved in adults.
Zoton, Lederle: New Zealand
capsule 30 mg
New indication: Eradication of Helicobacter pylori in patients with a peptic ulcer or gastritis, in combination with appropriate antibiotics.
Losec, Astra: New Zealand
capsule 20 mg
New indication: Gastric and duodenal ulcers and/or erosions associated with nonsteroidal anti-inflammatory drugs.
Somac, Pharmacia & Upjohn: New Zealand
enteric coated capsule 40 mg
cholinergic antisecretory agent; antiulcer agent
New indications: Long-term maintenance treatment of reflux oesophagitis; as part of triple therapy for the eradication of Helicobacter pylori associated with peptic ulcer disease.